$-0.08
(Market cap
$0 Mln
Revenue (TTM)
$8 Mln
P/E Ratio
--
P/B Ratio
14.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-6.2 %
-
ROCE
-- %
-
Industry P/E
43.99
-
EV/EBITDA
-0.9
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-6.4
-
Face value
--
-
Shares outstanding
28,045,417
10 Years Aggregate
CFO
$-426.22 Mln
EBITDA
$-457.12 Mln
Net Profit
$-524.33 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
T2 Biosystms Inc (TTOO)
| -- | -- | -- | -- | -95.2 | -94.4 | -80.7 |
|
BSE Sensex*
| -11.2 | -4.2 | -9.2 | -7.4 | 6.8 | 8.7 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
T2 Biosystms Inc (TTOO)
| -93.2 | -95.6 | -94.5 | -58.4 | 6.0 | -61.1 | -26.8 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
T2 Biosystms Inc (TTOO)
|
0.0 | 0.0 | 7.7 | -43.0 | -398.4 | -- | -- | 14.5 |
| 7.9 | 5,216.3 | 6,552.2 | -551.4 | -4.3 | -9.9 | -- | 1.0 | |
| 267.4 | 7,156.9 | 2,589.9 | 168.8 | 21.4 | 2.5 | 44.4 | 1.0 | |
| 44.6 | 6,483.3 | 3,458.5 | -11.6 | 2.6 | -0.5 | -- | 2.7 | |
| 139.7 | 8,216.9 | 551.4 | -189.3 | -15.6 | -26.3 | -- | 12.2 | |
| 95.0 | 6,047.7 | 1,546.2 | 279.0 | 15.0 | 23.9 | 22.2 | 5.0 | |
| 178.8 | 9,363.6 | 1,558.5 | 76.3 | 19.6 | 9.5 | 44.3 | 11.8 | |
| 326.9 | 12,843.7 | 1,454.3 | 171.1 | 11.1 | 12.1 | 75.2 | 8.7 | |
| 112.4 | 6,121.4 | 763.3 | 51.4 | 11.7 | 2.5 | 119.3 | 2.8 | |
| 30.6 | 13,141.3 | 6,178.4 | 626.5 | 13.0 | 11.9 | 21.6 | 2.5 |
Shareholding Pattern
View DetailsAbout T2 Biosystms Inc (TTOO)
T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated... in 2006 and is based in Lexington, Massachusetts. Read more
-
President, CEO & Chairman
Mr. John J. Sperzel III, B.Sc.
-
President, CEO & Chairman
Mr. John J. Sperzel III, B.Sc.
-
Headquarters
Lexington, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for T2 Biosystms Inc (TTOO)
What is the current share price of T2 Biosystms Inc (TTOO) Today?
The share price of T2 Biosystms Inc (TTOO) is $0.00 (NASDAQ) as of 20-May-2026 16:00 EDT. T2 Biosystms Inc (TTOO) has given a return of -95.22% in the last 3 years.
What is the current PB & PE ratio of T2 Biosystms Inc (TTOO)?
Since, TTM earnings of T2 Biosystms Inc (TTOO) is negative, P/E ratio is not available.
The P/B ratio of T2 Biosystms Inc (TTOO) is 14.50 times as on 15-May-2026, a 398 premium to its peers’ median range of 2.91 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
-0.51
|
-0.91
|
|
2022
|
-0.18
|
-0.27
|
|
2021
|
0.00
|
-0.01
|
|
2020
|
-0.01
|
0.04
|
|
2019
|
0.00
|
0.00
|
What is the 52 Week High and Low of T2 Biosystms Inc (TTOO)?
The 52-week high and low of T2 Biosystms Inc (TTOO) are Rs 0.01 and Rs 0.01 as of 21-May-2026.
What is the market cap of T2 Biosystms Inc (TTOO)?
T2 Biosystms Inc (TTOO) has a market capitalisation of $ 0 Mln as on 15-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in T2 Biosystms Inc (TTOO)?
Before investing in T2 Biosystms Inc (TTOO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.